Stableford Capital II’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.56M | Buy |
19,941
+6,788
| +52% | +$795K | 0.89% | 23 |
|
|
2026
Q1 | $1.58M | Hold |
13,153
| – | – | 0.59% | 45 |
|
|
2025
Q4 | $1.38M | Hold |
13,153
| – | – | 0.5% | 59 |
|
|
2025
Q3 | $1.1M | Hold |
13,153
| – | – | 0.4% | 66 |
|
|
2025
Q2 | $1.11M | Hold |
13,153
| – | – | 0.42% | 56 |
|
|
2025
Q1 | $1.03M | Sell |
13,153
-7,941
| -38% | -$741K | 0.43% | 51 |
|
|
2024
Q4 | $2.1M | Sell |
21,094
-1,462
| -6% | -$151K | 0.83% | 30 |
|
|
2024
Q3 | $2.48M | Buy |
22,556
+1,267
| +6% | +$151K | 0.99% | 26 |
|
|
2024
Q2 | $2.68M | Buy |
21,289
+72
| +0.3% | +$9.27K | 1.05% | 20 |
|
|
2024
Q1 | $2.8M | Sell |
21,217
-588
| -3% | -$72.5K | 1.12% | 19 |
|
|
2023
Q4 | $2.58M | Sell |
21,805
-456
| -2% | -$47.3K | 1.11% | 21 |
|
|
2023
Q3 | $2.35M | Buy |
22,261
+569
| +3% | +$61.3K | 1.08% | 19 |
|
|
2023
Q2 | $2.29M | Buy |
+21,692
| New | +$2.46M | 1.01% | 21 |
|
|
2023
Q1 | – | Sell |
-14,584
| Closed | -$1.61M | – | 126 |
|
|
2022
Q4 | $1.61M | Hold |
14,584
| – | – | 0.87% | 24 |
|
|
2022
Q3 | $1.4M | Sell |
14,584
-168
| -1% | -$15K | 0.67% | 33 |
|
|
2022
Q2 | $1.29M | Hold |
14,752
| – | – | 0.6% | 30 |
|
|
2022
Q1 | $1.28M | Hold |
14,752
| – | – | 0.54% | 42 |
|
|
2021
Q4 | $1.16M | Buy |
14,752
+8,638
| +141% | +$688K | 0.49% | 50 |
|
|
2021
Q3 | $479K | Sell |
6,114
-6,505
| -52% | -$495K | 0.24% | 93 |
|
|
2021
Q2 | $981K | Buy |
12,619
+348
| +3% | +$25.9K | 0.47% | 49 |
|
|
2021
Q1 | $903K | Buy |
12,271
+128
| +1% | +$9.44K | 0.46% | 50 |
|
|
2020
Q4 | $948K | Buy |
12,143
+8,387
| +223% | +$641K | 0.56% | 44 |
|
|
2020
Q3 | $297K | Hold |
3,756
| – | – | 0.2% | 55 |
|
|
2020
Q2 | $277K | Hold |
3,756
| – | – | 0.21% | 52 |
|
|
2020
Q1 | $276K | Sell |
3,756
-4,046
| -52% | -$318K | 0.19% | 48 |
|
|
2019
Q4 | $677K | Sell |
7,802
-12
| -0.2% | -$986 | 0.62% | 43 |
|
|
2019
Q3 | $628K | Buy |
7,814
+60
| +0.8% | +$4.81K | 0.59% | 40 |
|
|
2019
Q2 | $620K | Sell |
7,754
-183
| -2% | -$14K | 0.6% | 35 |
|
|
2019
Q1 | $630K | Sell |
7,937
-541
| -6% | -$40.5K | 0.52% | 46 |
|
|
2018
Q4 | $618K | Sell |
8,478
-1,551
| -15% | -$109K | 0.66% | 45 |
|
|
2018
Q3 | $679K | Sell |
10,029
-1,252
| -11% | -$79.8K | 0.45% | 49 |
|
|
2018
Q2 | $653K | Sell |
11,281
-355
| -3% | -$20K | 0.42% | 44 |
|
|
2018
Q1 | $605K | Buy |
11,636
+857
| +8% | +$46.3K | 0.43% | 49 |
|
|
2017
Q4 | $579K | Buy |
10,779
+765
| +8% | +$42.4K | 0.39% | 55 |
|
|
2017
Q3 | $612K | Buy |
10,014
+623
| +7% | +$37.8K | 0.44% | 55 |
|
|
2017
Q2 | $574K | Buy |
9,391
+882
| +10% | +$53.7K | 0.46% | 55 |
|
|
2017
Q1 | $516K | Buy |
8,509
+4,665
| +121% | +$283K | 0.45% | 57 |
|
|
2016
Q4 | $216K | Buy |
+3,844
| New | +$225K | 0.28% | 54 |
|
Other funds holding MRK
ECSS
Stableford Capital II's MRK Position: Q2 2026 in Review
Stableford Capital II increased its Merck (MRK) stake by 52% in Q2 2026, buying an estimated $795K and bringing the position to 19,941 shares worth $2.56M. The position accounts for 0.89% of the portfolio, ranked #23.
Stableford Capital II first reported a position in MRK in Q4 2016 and has held it in 38 quarters since. The position peaked at $2.8M in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Stableford Capital II held 19,941 shares of Merck worth $2.56M as of Q2 2026.
- Stableford Capital II bought 6,788 Merck shares in Q2 2026, an estimated $795K.
- Merck made up 0.89% of Stableford Capital II's portfolio in Q2 2026, its #23 holding.
- Stableford Capital II first reported a position in Merck in Q4 2016 and has held it in 38 quarters since.
- Stableford Capital II's Merck position peaked at $2.8M in Q1 2024.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Stableford Capital II's 13F filing for Q2 2026, filed 6 Jul 2026.